These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26882174)

  • 1. Uncharged nucleoside inhibitors of β-1,4-galactosyltransferase with activity in cells.
    Jiang J; Kanabar V; Padilla B; Man F; Pitchford SC; Page CP; Wagner GK
    Chem Commun (Camb); 2016 Mar; 52(20):3955-8. PubMed ID: 26882174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 5'-glycyl derivatives of uridine as inhibitors of 1,4-β-galactosyltransferase.
    Paszkowska J; Kral K; Bieg T; Żaba K; Węgrzyk K; Jaśkowiak N; Molinaro A; Silipo A; Wandzik I
    Bioorg Chem; 2015 Feb; 58():18-25. PubMed ID: 25462623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and preliminary biological assay of uridine glycoconjugate derivatives containing amide and/or 1,2,3-triazole linkers.
    Pastuch-Gawolek G; Plesniak M; Komor R; Byczek-Wyrostek A; Erfurt K; Szeja W
    Bioorg Chem; 2017 Jun; 72():80-88. PubMed ID: 28384485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Preliminary Evaluation of Biological Activity of Glycoconjugates Analogues of Acyclic Uridine Derivatives.
    Komor R; Pastuch-Gawolek G; Krol E; Szeja W
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30104510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new concept for glycosyltransferase inhibitors: nonionic mimics of the nucleotide donor of the human blood group B galactosyltransferase.
    Schaefer K; Albers J; Sindhuwinata N; Peters T; Meyer B
    Chembiochem; 2012 Feb; 13(3):443-50. PubMed ID: 22223604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise syntheses of selective inhibitors against α-1,3-galactosyltransferase.
    Zhang GL; Zhang LH; Ye XS
    Org Biomol Chem; 2010 Nov; 8(22):5062-8. PubMed ID: 20820649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between glycosyltransferases and 2-deoxy glycosyl derivatives of uridine simulated by molecular docking.
    Wandzik I
    Acta Pol Pharm; 2008; 65(6):735-41. PubMed ID: 19172857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Base-modified UDP-sugars reduce cell surface levels of P-selectin glycoprotein 1 (PSGL-1) on IL-1β-stimulated human monocytes.
    Kanabar V; Tedaldi L; Jiang J; Nie X; Panina I; Descroix K; Man F; Pitchford SC; Page CP; Wagner GK
    Glycobiology; 2016 Oct; 26(10):1059-1071. PubMed ID: 27233805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 2-deoxy-hexopyranosyl derivatives of uridine as donor substrate analogues for glycosyltransferases.
    Wandzik I; Bieg T; Czaplicka M
    Bioorg Chem; 2009 Dec; 37(6):211-6. PubMed ID: 19765794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptor substrate-based selective inhibition of galactosyltransferases.
    Chung SJ; Takayama S; Wong CH
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3359-64. PubMed ID: 9873734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and preliminary biological evaluations of 5'-substituted derivatives of uridine as glycosyltransferase inhibitors.
    Paszkowska J; Kral K; Bieg T; Nawrot U; Szeja W; Wandzik I
    Molecules; 2013 Jul; 18(7):8018-27. PubMed ID: 23884133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I.
    Montgomery AP; Dobie C; Szabo R; Hallam L; Ranson M; Yu H; Skropeta D
    Bioorg Med Chem; 2020 Jul; 28(14):115561. PubMed ID: 32616185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first C-glycosidic analogue of a novel galactosyltransferase inhibitor.
    Descroix K; Wagner GK
    Org Biomol Chem; 2011 Mar; 9(6):1855-63. PubMed ID: 21267505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile Solid-Phase Synthesis and Assessment of Nucleoside Analogs as Inhibitors of Bacterial UDP-Sugar Processing Enzymes.
    Madec AGE; Schocker NS; Sanchini S; Myratgeldiyev G; Das D; Imperiali B
    ACS Chem Biol; 2018 Sep; 13(9):2542-2550. PubMed ID: 30080379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on novel bacterial translocase I inhibitors, A-500359s. IV. Biosynthesis of A-500359s.
    Ohnuki T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2003 Mar; 56(3):268-79. PubMed ID: 12760683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoconjugates, products of uridine derivatives phosphitylation and oxidation as glycosyltransferases potential inhibitors.
    Grec M; Swierk P; Pastuch G; Szeja W
    Acta Pol Pharm; 2010; 67(6):652-63. PubMed ID: 21229882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of murine melanoma xylosyltransferase and galactosyltransferase activities and their inactivation by dialdehyde nucleosides.
    Lee MH; Lazo JS; Li CD; Hadfield AF; Maniglia CA; Sartorelli AC
    Chem Biol Interact; 1982 Aug; 41(2):141-53. PubMed ID: 6809344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide.
    Brunschweiger A; Iqbal J; Umbach F; Scheiff AB; Munkonda MN; Sévigny J; Knowles AF; Müller CE
    J Med Chem; 2008 Aug; 51(15):4518-28. PubMed ID: 18630897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Escherichia coli glycosyltransferase MurG and Mycobacterium tuberculosis Gal transferase by uridine-linked transition state mimics.
    Trunkfield AE; Gurcha SS; Besra GS; Bugg TD
    Bioorg Med Chem; 2010 Apr; 18(7):2651-63. PubMed ID: 20226679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of galactosyltransferases by a novel class of donor analogues.
    Descroix K; Pesnot T; Yoshimura Y; Gehrke SS; Wakarchuk W; Palcic MM; Wagner GK
    J Med Chem; 2012 Mar; 55(5):2015-24. PubMed ID: 22356319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.